Ledger.Open graph →
SEC Form D · Amendment · filed July 9, 2019

CARISMA Therapeutics Inc

Offering
$54.2M
Sold
$29.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Dan Rabinowitz · San Antonio, TXDirectorTony Padgett · San Antonio, TXDirectorLaura Velarde · San Antonio, TXDirectorMarty Neese · SAN ANTONIO, TXDirectorRobert Scofield · San Antonio, TXDirectorMike Kienitz · San Antonio, TXExec · DirectorBrennen Degner · PLAYA VISTA, CADirectorPatrick Reilly · Brighton, MAExec · DirectorDevin Antin · PLAYA VISTA, CADirectorRishi Srivastava · Franklin Lakes, NJDirectorMadhav Krishna · Franklin Lakes, NJDirectorSuren Dutia · Franklin Lakes, NJDirectorHy Levitsky · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗